NEW YORK, United States — SuperiorMed Holdings Limited announced that it entered into an official Agreement and Plan of Merger on August 22, 2026, to execute a business combination with Starry Sea Acquisition Corp, a Nasdaq-listed blank check company trading under the ticker SSEA.
The complex transaction structure involves the merger of SSEA into SuperiorMed Healthcare Group, a newly established Cayman Islands exempted company and wholly owned subsidiary of the SPAC. Concurrently, SuperiorMed Healthcare MergerCo will merge directly into SuperiorMed Holdings, establishing the primary operating entity as a wholly owned subsidiary of the newly formed parent enterprise. Upon the successful completion of the transaction, the surviving parent organization is slated to become a publicly traded corporation, with existing security holders from both entities receiving ordinary shares.
Transaction Terms and Governance Structure
Under the terms approved unanimously by the boards of directors of both companies, existing SuperiorMed shareholders and SSEA security holders will transition their holdings into ordinary shares of the public parent entity. To ensure market stability following the transition, certain key shareholders associated with SuperiorMed will be bound by a mandatory 180-day post-closing lock-up agreement.
While the initial announcement outlines the structural roadmap of the combination, specific financial metrics regarding share counts, exact exchange ratios, and precise ownership percentages remain undisclosed in the preliminary filings. Financial analysts are closely tracking the upcoming proxy statements to gauge the ultimate equity dilution and valuation parameters.
Regulatory Approvals and Next Steps
The realization of the business combination depends on satisfying multiple customary closing conditions. These prerequisites include securing green lights from both SSEA and SuperiorMed shareholders, obtaining necessary regulatory clearances, ensuring the effectiveness of a registration statement filed with the U.S. Securities and Exchange Commission (SEC), and securing formal stock-exchange listing approval.
Market observers note that SSEA's recent financial disclosures indicate tight operating cash runways, making the prompt progression of the merger timeline critical for the SPAC entity. Both leadership teams are moving forward with documentation to meet preliminary filing milestones ahead of the upcoming proxy vote windows.
Why did SuperiorMed and Starry Sea Acquisition Corp enter into this merger agreement?
SuperiorMed and Starry Sea Acquisition Corp entered into the merger agreement to transition SuperiorMed into a publicly traded company via a SPAC business combination, allowing the healthcare management platform to access public capital markets and expand its corporate footprint following unanimous board approvals secured on August 22, 2026.
The definitive transaction agreement was executed on August 22, 2026.
An extraordinary general meeting for shareholder voting and final regulatory clearances is anticipated to proceed following SEC registration statement effectiveness.